Abstract
Exposure to chronic hypoxia (CH) initiates cellular responses designed to counteract this deleterious stimulus, providing a physiological response to low oxygen. However, long-term exposure to CH, such as that which occurs in cardiorespiratory diseases such as ischaemic stroke, can also have pathological consequences. In many cases, CH alters the transcription of genes encoding numerous proteins, secondary to accumulation of the transcriptional activator hypoxia inducible factor-1 (HIF-1) (Schofield and Ratcliffe, 2004). In contrast, we recently reported that hypoxic regulation of the plasma membrane expression of L-type Ca2+ channel α1c subunits occurred in a post-transcriptional manner due to the trafficking of these subunits towards, and / or their retention within, the plasma membrane (Scragg et al., 2004). This process involved the altered production of amyloid β peptides (A Ps), since it was inhibited by selective inhibitors of the secretases involved in the production of these peptides, and mimicked by exogenous AβP. This regulation of the functional membrane expression of a voltage-gated Ca2+ channel may contribute to the Ca2+ dyshomeostasis seen in Alzheimer’s disease, a prevalent disorder in which hypoxia / ischaemia is a predisposing factor (Moroney et al., 1996).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramov, A.Y., Canevari, L. and Duchen, M.R. (2004). Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci. 24, 565–575.
Hensley, K., Carney, J.M., Mattson, M.P., Aksenova, M., Harris, M., Wu, J.F., Floyd, R.A. and Butterfield, D.A. (1994). A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 3270–3274.
Hudasek, K., Brown, S.T. and Fearon, I.M. (2004). H2O2 regulates recombinant Ca2+ channel a1C subunits but does not mediate their sensitivity to acute hypoxia. Biochem. Biophys. Res. Commun. 318, 135–141.
King, M.P. and Attardi, G. (1989). Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246, 500–503.
Mattson, M.P. (1997). Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives, Physiol. Rev. 77, 1081–1132.
Moroney, J.T., Bagiella, E., Desmond, D.W., Paik, M.C., Stern, Y. and Tatemichi, T.K. (1996). Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 27, 1283–1289.
Schofield, C.J. and Ratcliffe, P.J. (2004). Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343–354.
Scragg, J.L., Fearon, I.M., Boyle, J., Ball, S.G., Varadi, G. and Peers, C. (2004). Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels. FASEB J. 19, 150–152.
Smith, M.A., Drew, K.L., Nunomura, A., Takeda, A., Hirai, K., Zhu, X., Atwood, C.S., Raina, A.K., Rottkamp, C.A., Sayre, L.M., Friedland, R.P. and Perry, G. (2002). Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochem. Int. 40, 527–531.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this paper
Cite this paper
FEARON, I.M., BROWN, S.T., HUDASEK, K., SCRAGG, J.L., BOYLE, J.P., PEERS, C. (2006). Mitochondrial ROS Production Initiates Aβ1-40-Mediated Up-Regulation of L-Type Ca2+ Channels during Chronic Hypoxia. In: Hayashida, Y., Gonzalez, C., Kondo, H. (eds) THE ARTERIAL CHEMORECEPTORS. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, vol 580. Springer, Boston, MA. https://doi.org/10.1007/0-387-31311-7_30
Download citation
DOI: https://doi.org/10.1007/0-387-31311-7_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-31310-8
Online ISBN: 978-0-387-31311-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)